← All indications
Influenza, Human
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
Drugs by status
Approved for this indication (18)
- live attenuated influenza virus vaccine
- inactivated influenza vaccine
- matrix m1
- amantadine
- ergoferon
- rimantadine
- umifenovir
- zanamivir
- oseltamivir
- pseudoephedrine
- virosomal influenza vaccine
- triazavirin
- fufangshuanghua
- baloxavir marboxil
- acetaminophen
- influenza virus vaccine, intradermal
- peramivir
- ethylmercurithiosalicylic acid
Phase 4 trials (49)
- azficel-T
- covid19 recombinant spike protein
- tivantinib
- azithromycin
- as03
- reduning
- lactobacillus rhamnosus
- vitamin c
- alfarix
- european elderberry
- typhoid vi polysaccharide vaccine
- desflurane
- flulaval
- fluoxetine
- subunit influenza vaccine
- split virion influenza vaccine
- dextrose
- ibuprofen
- mf59
- 23-valent pneumococcal polysaccharide vaccine
- sirolimus
- imiquimod
- Inactivated polio virus - Enhanced
- typhoid vaccine, live oral
- clarithromycin
- interferon gamma-1b
- multi-valent pneumococcal conjugate vaccine
- procaine benzylpenicillin
- banlangen
- ev71 vaccine
- +19 more
Phase 3 trials (52)
- av5080
- gsk2186877a
- mmh-407
- vitis vinifera
- bacille calmette-guerin
- tea
- diphtheria toxoid
- live attenuated varicella vaccine
- lansoprazole
- quadrivalent influenza moderna vaccine
- influenza vlp vaccine
- mrna-1083
- methotrexate
- histamine
- phosphate
- mrna-1010
- enisamium iodide
- nitazoxanide
- chlorpheniramine
- meglumine
- Thimerosal
- tick-borne encephalitis vaccine
- bifidobacterium lactis
- miglyol oil
- vitamin d3
- laninamivir octanoate hydrate
- dexamethasone
- Bivalent group A and C meningococcal vaccine
- xc8
- fludarabine
- +22 more
Phase 2 trials (83)
- bbibp-corv
- bimervax
- mva-np
- cr8020
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- a/vietnam/1203/04 vaccine
- h5n8 antigen
- chloroquine
- ad07010
- influenza virus vaccine, monovalent a/h3n2v a/minnesota/11/2010 nymc x-203
- subunit herpes zoster vaccine
- tiv mrna-neuraminidase
- aIIV-B
- vax2012q
- gsk2584786a
- multimeric-001
- lactose
- tak-850
- h5n1 antigen
- medi8852
- gsk1247446a
- chadox1
- avm0703
- baicalein
- proteosome influenza vaccine
- adjuvanted flu-v
- lactobacillus fermentum
- isa-51
- vax102
- ghb16l2
- +53 more
Phase 1 trials (108)
- avi-7100
- val-339851
- live influenza a vaccine h7n3 (6-2) aa ca recombinant (a/chicken/british columbia/cn-6/2004 x a/ann arbor/6/60 ca)
- sfericase
- zsp1273
- vcl-ipt1
- zapnometinib
- vrc-flunpf081-00-vp
- gsk3277509a
- ppml7789
- a/mallard/ohio-99/mm4/1989 h10n7
- ppjv2012
- vrc-flunpf099-00-vp
- vax161
- advax
- vrc-avidna036-00-vp
- val-506440
- vrc-flumos0116-00-vp
- a/ann arbor/6/60 ca vaccine
- vnt-101
- gsk3277510a
- tiv-2x
- fdq21a-nh
- a/swine/missouri/4296424/2006 vaccine
- fgi-101-1a6
- hnc042
- qirv
- mrna-1230
- dei-lt (ppjv2012)
- fvh1
- +78 more
Organizations
Organization Involved with Phase 4 Indications (214)
- National University of Singapore
- Radboud University
- Peking University
- Institut National de la Santé Et de la Recherche Médicale, France
- VisMederi srl
- Eurogenerics NV
- PHAC/CIHR Influenza Research Network
- Crucell
- Pharmstandard
- National Institutes of Health (NIH)
- German Federal Institute of Sport Science
- Uppsala University
- Influenza Foundation of Thailand
- Pharmahungary Group
- Boehringer Ingelheim
- Capital Medical University
- Pharmacare PLC, Palestine
- Case Western Reserve University
- Department of Veteran Affairs
- Adimmune Corporation
- University of Chicago
- University of Washington
- GlaxoSmithKline
- Southern Medical University
- University of British Columbia
- University of Turku
- China Academy of Chinese Medical Sciences
- Swedish Heart Lung Foundation
- Hospital Nacional San Juan de Dios de Santa Ana, El Salvador
- Mount Sinai Hospital, Canada
- +184 more
Organization Involved with Phase 3 Indications (156)
- Atlant Clinical Ltd.
- Chungbuk National University
- Stellenbosch University
- ILS Clinical Research
- Benchmark Research
- NPO Petrovax Pharm LLC
- Inje University
- Maine Research Associates
- University of Ulsan
- Chonbuk National University
- Rapid Medical Research, Inc.
- COMPLEJO HOSPITALARIO REGIONAL VIRGEN MACARENA
- Hong Kong Government
- Siriraj Hospital
- International Center for Diarrheal Disease Research
- Baxalta
- Farmak
- Tribhuvan University
- Kyungpook University
- Sungkyunkwan University
- Institute of Virology, Vaccines and Sera, Torlak
- Thrasher Research Fund
- Government of Brazil
- Cha Medical University
- Chiron
- Research Institute of Influenza, Russia
- Ontario HIV Treatment Network
- HOSPITAL UNIVERSITARIO DE CRUCES
- Bassett Healthcare
- Chonnam National University
- +126 more
Organization Involved with Phase 2 Indications (198)
- Alpine Clinical Research Center
- Omega Medical Research
- INC Research
- Therapix Biosciences Ltd.
- MDS Pharma
- Yale University
- Best Quality Research, Hialeah, FL
- Leidos
- Lovelace Scientific Resources, Inc., Venice, FL
- SGS Life Sciences
- Clinical Trial Connection, Flagstaff, AZ
- Medical Research Council
- Midwest Allergy and Asthma Clinic, P.C., Omaha
- Clinique medicale des Campus
- Montana Health Research Institute Inc., Billings
- Russian Institute of Influenza
- Dayton Clinical Research
- University of Groningen
- Eurocine Vaccines AB
- University of Bristol
- Rochester Clinical Research
- Towngate Plaza Medical Center
- Sunrise Medical Research, Inc.
- Vertex
- Biosearch S.A.
- Clinical Research Solutions
- St. Joseph's Medical Associates, Stockton, CA
- Integrated Medical Research, PC
- Comprehensive Clinical Research
- Wishard Hospital
- +168 more
Organization Involved with Phase 1 Indications (55)
- Sarepta Therapeutics
- Medyag Ltd.
- VA Pharma Limited Liability Company
- Infectious Disease Research Institute
- The EMMES Corporation
- Kentucky BioProcessing, Inc.
- Shin Nippon Biomedical Laboratories
- Amerifit Brands Inc
- Georgia Institute of Technology
- Q-Pharm
- University of Texas, Galveston
- Nova Immunotherapeutics Limited
- University of California, Los Angeles
- Drug Research Center Ltd.
- PowderMed
- Canadian Science Centre for Human and Animal Health
- Flinders University
- Russian Military
- Pulmatrix Inc.
- Microgen Scientific Industrial Company for Immunobiological Medicines
- Hospital Universitario da USP
- FluGen Inc
- Australian Respiratory and Sleep Medicine Institute
- Health Sciences Centre Foundation, Manitoba
- Vical
- Mercia Pharma Inc.
- Vaxine Pty Ltd
- J. Craig Venter Institute
- National Center for Complementary and Integrative Health (NCCIH)
- WCCT Global
- +25 more
Organization Involved with Other Experimental Indications (41)
- White Cross Nursing Home
- Chulalongkorn University
- Vabiotech
- University of Ljubljana
- Vietstar Biomedical Research
- National Institute for Health Research, United Kingdom
- Qingfeng Pharmaceutical Group
- Bhumirajanagarindra Kidney Institute, Thailand
- Sint Antonius Hospital, Nieuwegein
- University of Massachusetts
- Hillel Yaffe Medical Center
- Group Health Cooperative
- Makerere University
- St. Antonius Hospital, Nieuwegein
- Seirei Hamamatsu General Hospital
- The Research Grants Council, Hong Kong
- Centre of Postgraduate Medical Education
- National Center for Occupational Health and Infection Control
- Inner Mongolia Yili Industrial Group Co., Ltd
- Huazhong University of Science and Technology
- University of Queensland
- Northumbria University
- Taipei Medical University
- NanoPass Technologies Ltd
- Utrecht University
- Hamamatsu University
- Narayana Hrudayalaya Limited
- University of Nottingham
- Liaoning Hospital of Traditional Chinese Medicine
- University of Arizona
- +11 more